Report Detail

Pharma & Healthcare Dynamics in Post-pandemic Global Anthelmintic Drugs Industry: Supply and Demand, Markets and Prices 2021-2027

  • RnM4319585
  • |
  • 27 May, 2021
  • |
  • Global
  • |
  • 134 Pages
  • |
  • GRD Survey
  • |
  • Pharma & Healthcare

Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Anthelmintic Drugs market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Anthelmintic Drugs market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Oral Drugs
Injectables

Segmented by End User/Segment
For Human
For Animal

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Sun Pharmaceutical Industries
Pfizer
Novartis
Merck
Mankind Pharma
Johnson & Johnson
Cipla
Bayer


Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Anthelmintic Drugs Market Status and Forecast (2016-2027)
      • 1.3.2 Global Anthelmintic Drugs Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Anthelmintic Drugs Supply by Company

    • 2.1 Global Anthelmintic Drugs Sales Volume by Company
    • 2.2 Global Anthelmintic Drugs Sales Value by Company
    • 2.3 Global Anthelmintic Drugs Price by Company
    • 2.4 Anthelmintic Drugs Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Anthelmintic Drugs Market Status by Category

    • 3.1 Anthelmintic Drugs Category Introduction
      • 3.1.1 Oral Drugs
      • 3.1.2 Injectables
    • 3.2 Global Anthelmintic Drugs Market by Category
      • 3.2.1 Global Anthelmintic Drugs Sales Volume by Category (2016-2021)
      • 3.2.2 Global Anthelmintic Drugs Sales Value by Category (2016-2021)
      • 3.2.3 Global Anthelmintic Drugs Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Anthelmintic Drugs Market Status by End User/Segment

    • 4.1 Anthelmintic Drugs Segment by End User/Segment
      • 4.1.1 For Human
      • 4.1.2 For Animal
    • 4.2 Global Anthelmintic Drugs Market by End User/Segment
      • 4.2.1 Global Anthelmintic Drugs Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Anthelmintic Drugs Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Anthelmintic Drugs Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Anthelmintic Drugs Market Status by Region

    • 5.1 Global Anthelmintic Drugs Market by Region
      • 5.1.1 Global Anthelmintic Drugs Sales Volume by Region
      • 5.1.2 Global Anthelmintic Drugs Sales Value by Region
    • 5.2 North America Anthelmintic Drugs Market Status
    • 5.3 Europe Anthelmintic Drugs Market Status
    • 5.4 Asia Pacific Anthelmintic Drugs Market Status
    • 5.5 Central & South America Anthelmintic Drugs Market Status
    • 5.6 Middle East & Africa Anthelmintic Drugs Market Status

    6 North America Anthelmintic Drugs Market Status

    • 6.1 North America Anthelmintic Drugs Market by Country
      • 6.1.1 North America Anthelmintic Drugs Sales Volume by Country (2016-2021)
      • 6.1.2 North America Anthelmintic Drugs Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Anthelmintic Drugs Market Status

    • 7.1 Europe Anthelmintic Drugs Market by Country
      • 7.1.1 Europe Anthelmintic Drugs Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Anthelmintic Drugs Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Anthelmintic Drugs Market Status

    • 8.1 Asia Pacific Anthelmintic Drugs Market by Country
      • 8.1.1 Asia Pacific Anthelmintic Drugs Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Anthelmintic Drugs Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Anthelmintic Drugs Market Status

    • 9.1 Central & South America Anthelmintic Drugs Market by Country
      • 9.1.1 Central & South America Anthelmintic Drugs Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Anthelmintic Drugs Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Anthelmintic Drugs Market Status

    • 10.1 Middle East & Africa Anthelmintic Drugs Market by Country
      • 10.1.1 Middle East & Africa Anthelmintic Drugs Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Anthelmintic Drugs Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Anthelmintic Drugs Manufacturing Cost Analysis
    • 11.5 Anthelmintic Drugs Sales Channel and Distributors Analysis
      • 11.5.1 Anthelmintic Drugs Sales Channel
      • 11.5.2 Anthelmintic Drugs Distributors
    • 11.6 Anthelmintic Drugs Downstream Major Buyers

    12 Global Anthelmintic Drugs Market Forecast by Category and by End User/Segment

    • 12.1 Global Anthelmintic Drugs Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Anthelmintic Drugs Forecast by Category
      • 12.2.1 Global Anthelmintic Drugs Sales Volume Forecast by Category
      • 12.2.2 Global Anthelmintic Drugs Sales Value Forecast by Category
      • 12.2.3 Global Anthelmintic Drugs Price Forecast by Category
    • 12.3 Global Anthelmintic Drugs Forecast by End User/Segment
      • 12.3.1 Global Anthelmintic Drugs Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Anthelmintic Drugs Sales Value Forecast by End User/Segment
      • 12.3.3 Global Anthelmintic Drugs Price Forecast by End User/Segment

    13 Global Anthelmintic Drugs Market Forecast by Region/Country

    • 13.1 Global Anthelmintic Drugs Market Forecast by Region (2022-2027)
      • 13.1.1 Global Anthelmintic Drugs Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Anthelmintic Drugs Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Sun Pharmaceutical Industries
      • 14.1.1 Company Information
      • 14.1.2 Anthelmintic Drugs Product Introduction
      • 14.1.3 Sun Pharmaceutical Industries Anthelmintic Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Pfizer
      • 14.2.1 Company Information
      • 14.2.2 Anthelmintic Drugs Product Introduction
      • 14.2.3 Pfizer Anthelmintic Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Novartis
      • 14.3.1 Company Information
      • 14.3.2 Anthelmintic Drugs Product Introduction
      • 14.3.3 Novartis Anthelmintic Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Merck
      • 14.4.1 Company Information
      • 14.4.2 Anthelmintic Drugs Product Introduction
      • 14.4.3 Merck Anthelmintic Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Mankind Pharma
      • 14.5.1 Company Information
      • 14.5.2 Anthelmintic Drugs Product Introduction
      • 14.5.3 Mankind Pharma Anthelmintic Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Johnson & Johnson
      • 14.6.1 Company Information
      • 14.6.2 Anthelmintic Drugs Product Introduction
      • 14.6.3 Johnson & Johnson Anthelmintic Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Cipla
      • 14.7.1 Company Information
      • 14.7.2 Anthelmintic Drugs Product Introduction
      • 14.7.3 Cipla Anthelmintic Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Bayer
      • 14.8.1 Company Information
      • 14.8.2 Anthelmintic Drugs Product Introduction
      • 14.8.3 Bayer Anthelmintic Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Summary:
      Get latest Market Research Reports on Anthelmintic Drugs. Industry analysis & Market Report on Anthelmintic Drugs is a syndicated market report, published as Dynamics in Post-pandemic Global Anthelmintic Drugs Industry: Supply and Demand, Markets and Prices 2021-2027. It is complete Research Study and Industry Analysis of Anthelmintic Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,980.00
      $4,470.00
      $5,960.00
      2,392.94
      3,589.41
      4,785.88
      2,786.30
      4,179.45
      5,572.60
      462,287.40
      693,431.10
      924,574.80
      248,383.00
      372,574.50
      496,766.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report